150 related articles for article (PubMed ID: 32101694)
1. Diagnosis of prostate cancer: the implications and proper utilization of PSA and its variants; indications and use of MRI and biomarkers.
Law KW; Nguyen DD; Barkin J; Zorn KC
Can J Urol; 2020 Feb; 27(27 Suppl 1):3-10. PubMed ID: 32101694
[TBL] [Abstract][Full Text] [Related]
2. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
Carter HB
BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in the PSA screening era.
George AK; Pinto PA; Rais-Bahrami S
Biomed Res Int; 2014; 2014():465816. PubMed ID: 25250323
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer: the current evidence and guidelines controversy.
Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
[TBL] [Abstract][Full Text] [Related]
5. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
6. [Austrian patient information materials on PSA-screening do not meet international evidence-based standards].
Strobelberger M; Kaminski A; Gartlehner G
Wien Med Wochenschr; 2011 Feb; 161(3-4):89-98. PubMed ID: 21253813
[TBL] [Abstract][Full Text] [Related]
7. Advances in the diagnostic options for prostate cancer.
French WW; Wallen EM
Postgrad Med; 2020 Dec; 132(sup4):52-62. PubMed ID: 32900250
[TBL] [Abstract][Full Text] [Related]
8. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
[TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
10. Screening for Prostate Cancer.
Carlsson SV; Vickers AJ
Med Clin North Am; 2020 Nov; 104(6):1051-1062. PubMed ID: 33099450
[TBL] [Abstract][Full Text] [Related]
11. [Focus on the screening for prostate cancer by PSA].
Roumeguère T; Van Velthoven R
Rev Med Brux; 2013 Sep; 34(4):311-9. PubMed ID: 24195246
[TBL] [Abstract][Full Text] [Related]
12. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen-based prostate cancer screening: Past and future.
Alberts AR; Schoots IG; Roobol MJ
Int J Urol; 2015 Jun; 22(6):524-32. PubMed ID: 25847604
[TBL] [Abstract][Full Text] [Related]
14. PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice.
Wilt TJ; Dahm P
J Natl Compr Canc Netw; 2015 Dec; 13(12):1566-74. PubMed ID: 26656523
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
Borofsky MS; Makarov DV
Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
[No Abstract] [Full Text] [Related]
16. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
Eapen RS; Herlemann A; Washington SL; Cooperberg MR
Curr Opin Urol; 2017 May; 27(3):205-209. PubMed ID: 28221220
[TBL] [Abstract][Full Text] [Related]
17. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
Kovács GL
Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
[TBL] [Abstract][Full Text] [Related]
18. [Current results on PSA-based prostate cancer detection].
Graefen M; Schlomm T; Steuber T; Sauter G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
Duffy MJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):310-6. PubMed ID: 21525152
[TBL] [Abstract][Full Text] [Related]
20. Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.
Feng B; Srinivasan M; Hoffman JR; Rainwater JA; Griffin E; Dragojevic M; Day FC; Wilkes MS
Ann Fam Med; 2013; 11(4):315-23. PubMed ID: 23835817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
